Sarasin & Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $102M | Sell |
|
|||||
|
2025
Q2 | $185M | Buy |
|
|||||
|
2025
Q1 | $188M | Sell |
|
|||||
|
2024
Q4 | $197M | Buy |
|
|||||
|
2024
Q3 | $213M | Sell |
|
|||||
|
2024
Q2 | $285M | Buy |
|
|||||
|
2024
Q1 | $215M | Buy |
|
|||||
|
2023
Q4 | $144M | Buy |
|
|||||
|
2023
Q3 | $5.38M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $43.2M | Buy |
|
|||||
|
2022
Q4 | $10.8M | Sell |
|
|||||
|
2022
Q3 | $16.7M | Sell |
|
|||||
|
2022
Q2 | $27.2M | Sell |
|
|||||
|
2022
Q1 | $36.6M | Hold |
|
|||||
|
2021
Q4 | $35.3M | Hold |
|
|||||
|
2021
Q3 | $29.5M | Hold |
|
|||||
|
2021
Q2 | $29.3M | Buy |
|
|||||
|
2021
Q1 | $22.8M | Sell |
|
|||||
|
2020
Q4 | $25.8M | Buy |
|
|||||
|
2020
Q3 | $19.2M | Buy |
|
|||||
|
2020
Q2 | $9.46M | Hold |
|
|||||
|
2020
Q1 | $7.99M | Buy |
|
|||||
|
2019
Q4 | $5.85M | Hold |
|
|||||
|
2019
Q3 | $4.98M | Buy |
|
|||||
|
2019
Q2 | $3.04M | Buy |
|
|||||
|
2019
Q1 | $3.4M | Hold |
|
|||||
|
2018
Q4 | $3.03M | Sell |
|
|||||
|
2018
Q3 | $3.57M | Buy |
|